(Q26773290)

English

Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26694529%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

based on heuristic

inferred from title

2 references

30 May 2020

13 July 2020

systematic review

0 references

Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26694529%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

2 references

19 March 2019

13 July 2020

1 reference

heterocyclic compound

1 reference

17 September 2019

polycyclic compound

1 reference

13 November 2019

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

alcohol dependence

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26694529%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Clément Palpacuer

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26694529%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Bruno Laviolle

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26694529%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Rémy Boussageon

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26694529%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jean Michel Reymann

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26694529%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Eric Bellissant

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26694529%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

0 references

publication date

22 December 2015

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26694529%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 December 2015

2 references

30 May 2020

13 July 2020

6 references

19 March 2019

17 September 2019

13 November 2019

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26694529%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

30 May 2020

13 July 2020

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26694529%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26694529%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

e1001924

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26694529%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

copyright license

Creative Commons Attribution 4.0 International

5 references

Europe PubMed Central

19 March 2019

Europe PubMed Central

17 September 2019

Europe PubMed Central

13 November 2019

Europe PubMed Central

30 May 2020

Europe PubMed Central

13 July 2020

copyright status

0 references

on focus list of Wikimedia project

0 references

Nalmefene: a new approach to the treatment of alcohol dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

7 April 2017

Managed alcohol as a harm reduction intervention for alcohol addiction in populations at high risk for substance abuse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

7 April 2017

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

7 April 2017

Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

7 April 2017

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

7 April 2017

Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

7 April 2017

Clinical relevance of nalmefene versus placebo in alcohol treatment: reduction in mortality risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

Alcohol harm reduction: corporate capture of a key concept

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

Methods to analyze treatment effects in the presence of missing data for a continuous heavy drinking outcome measure when participants drop out from treatment in alcohol clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

Bad medicine: nalmefene in alcohol misuse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

How to use a subgroup analysis: users' guide to the medical literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

Credibility of claims of subgroup effects in randomised controlled trials: systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

Reporting attrition in randomised controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

Harm reduction approaches to alcohol use: health promotion, prevention, and treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687857

28 September 2017

A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1001924

21 January 2018

Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1001924

21 January 2018

A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1001924

21 January 2018

Longitudinal association between frequency of substance use and quality of life among adolescents receiving a brief outpatient intervention

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1001924

21 January 2018

Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1001924

21 January 2018

Naltrexone and nalmefene: any meaningful difference?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1001924

21 January 2018

Nalmefene in alcohol misuse: junk evaluation by the European Medicines Agency

1 reference

https://pubmed.ncbi.nlm.nih.gov/26694529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

German evaluation says new drug for alcohol dependence is no better than old one

1 reference

https://pubmed.ncbi.nlm.nih.gov/26694529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias?

1 reference

https://pubmed.ncbi.nlm.nih.gov/26694529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Harm reduction approaches to alcohol use

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1001924

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1371/JOURNAL.PMED.1001924

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26694529%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26694529%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

PubMed publication ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26694529%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26773290&oldid=1966170495"